Cargando…
Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Endocrine Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419613/ https://www.ncbi.nlm.nih.gov/pubmed/34474520 http://dx.doi.org/10.3803/EnM.2021.1193 |
| _version_ | 1783748789286207488 |
|---|---|
| author | Kim, Bu Kyung Kim, Chong Hwa Min, Yong-Ki |
| author_facet | Kim, Bu Kyung Kim, Chong Hwa Min, Yong-Ki |
| author_sort | Kim, Bu Kyung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8419613 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Korean Endocrine Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84196132021-09-14 Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society Kim, Bu Kyung Kim, Chong Hwa Min, Yong-Ki Endocrinol Metab (Seoul) Letter Korean Endocrine Society 2021-08 2021-08-27 /pmc/articles/PMC8419613/ /pubmed/34474520 http://dx.doi.org/10.3803/EnM.2021.1193 Text en Copyright © 2021 Korean Endocrine Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Kim, Bu Kyung Kim, Chong Hwa Min, Yong-Ki Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society |
| title | Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society |
| title_full | Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society |
| title_fullStr | Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society |
| title_full_unstemmed | Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society |
| title_short | Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society |
| title_sort | preventing rebound-associated fractures after discontinuation of denosumab therapy: a position statement from the health insurance committee of the korean endocrine society |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419613/ https://www.ncbi.nlm.nih.gov/pubmed/34474520 http://dx.doi.org/10.3803/EnM.2021.1193 |
| work_keys_str_mv | AT kimbukyung preventingreboundassociatedfracturesafterdiscontinuationofdenosumabtherapyapositionstatementfromthehealthinsurancecommitteeofthekoreanendocrinesociety AT kimchonghwa preventingreboundassociatedfracturesafterdiscontinuationofdenosumabtherapyapositionstatementfromthehealthinsurancecommitteeofthekoreanendocrinesociety AT minyongki preventingreboundassociatedfracturesafterdiscontinuationofdenosumabtherapyapositionstatementfromthehealthinsurancecommitteeofthekoreanendocrinesociety |